Close search filters
Changing filters will change the listed Success Criteria and Techniques
Category
Topic
Search results (149)
Article
Nurses Improve Health Outcomes
May 13, 2022
Whether nurses have direct interaction with patients or work in non-traditional roles, their knowledge and expertise can improve health outcomes for patients.
Article
How Evernorth helps providers and health systems deliver comprehensive care to patients
July 11, 2024
Today, health systems are facing a variety of challenges, among them, staffing shortages, rapidly increasing patient demand, and rising costs.
Video
Biosimilars 101
October 17, 2022
To help clients prepare for the wave of biosimilars on the horizon, we answer some basic questions about these potentially game-changing medications.
Article
Evernorth chief bullish on driving affordability through biosimilars and access through guided care
May 08, 2024
Article
PBMs and the drug pipeline: Anticipating tomorrow while affording today
October 04, 2024
Article
What to look for in the upcoming gene therapy pipeline
April 20, 2023
As the gene therapy landscape continues to evolve, plan sponsors should familiarize themselves with the tools and strategies necessary to navigate the future of these game-changing treatments.
Article
Leveraging biosimilars to drive savings and support patient access
By the end of 2024, 3 FDA-approved biosimilars to Stelara for patients living with inflammatory conditions will be closer to launch, enabling lower total drug spend.
Read MoreArticle
Boosting Biosimilars Competition and Savings
September 25, 2023
An Evernorth analysis estimates that biosimilar competition can deliver $225 billion to $375 billion in drug cost savings for plan sponsors by 2031. Learn strategies to capture these savings, while pr...
Article
Outcomes 2024: How Evernorth manages the drug pipeline today and prepares for tomorrow
May 08, 2024